John Eden
Revision as of 17:19, 6 March 2010 by Marisa de Andrade (talk | contribs) (New page: {{Template:Pharma_Portal_badge}} '''Dr. John Eden''' is Director of the Barbara Gross Research Unit, the Sydney Menopause Centre and the Natural Therapies Unit. He is Associate Professor ...)
|
This article is part of the Pharma_Portal project of Spinwatch. |
Dr. John Eden is Director of the Barbara Gross Research Unit, the Sydney Menopause Centre and the Natural Therapies Unit. He is Associate Professor of Reproductive Endocrinology at the University of New South Wales.[1] Eden signed his name to a paper ghostwritten by Wyeth, manufacturer of hormone replacement therapy (HRT), Prempro, and the medical communications company DesignWrite.[2]
Notes
- ↑ SMC.Staff: Sydney Menopause Centre Accessed 6 March 2010.
- ↑ Wilson, D. 12 December 2008. The New York Times. Drug Maker Said to Pay Ghostwriters for Journal Articles Accessed 6 March 2010.
